BeiGene
BeiGene (rebranded as BeOne Medicines in 2025) is a global oncology biopharmaceutical company founded in 2010, developing and commercializing cancer therapies worldwide. Its portfolio spans blood cancers and solid tumors, led by BRUKINSA (zanubrutinib), a BTK inhibitor, alongside programs in protein degradation (CDACs) and antibody-drug conjugates (ADCs). The company is listed on NASDAQ (BGNE), HKEX, and the Shanghai STAR Market, with a global footprint across 30+ countries (beonemedicines.com). Surfaced as a portfolio company of Hillhouse; no public developer portal, API, or SDK program is currently published.
BeiGene is profiled on the APIs.io network. Tagged areas include Company, Biotech, Pharmaceuticals, Oncology, and Healthcare.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API